litlas
Log inCreate account

Frederick L. Baehner

Active 2004–2025

60
Papers
27,008
Citations
44
h-index
54
i10-index

Citations

Citations per year for Frederick L. Baehner1981: 2 citations1988: 1 citations1998: 2 citations2002: 1 citations2004: 1 citations2005: 40 citations2006: 74 citations2007: 145 citations2008: 219 citations2009: 258 citations2010: 329 citations2011: 346 citations2012: 325 citations2013: 368 citations2014: 288 citations2015: 315 citations2016: 328 citations2017: 319 citations2018: 327 citations2019: 921 citations2020: 917 citations2021: 782 citations2022: 579 citations2023: 378 citations2024: 568 citations2025: 220 citations2026: 15 citations1982–1987: no citations, so these years are not shown1989–1997: no citations, so these years are not shown1999–2001: no citations, so these years are not shown2003: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,136 citing papers, 28.4% of this breakdownChina: 851 citing papers, 7.7% of this breakdownUnited Kingdom: 711 citing papers, 6.4% of this breakdownItaly: 528 citing papers, 4.8% of this breakdownGermany: 465 citing papers, 4.2% of this breakdownCanada: 458 citing papers, 4.2% of this breakdownFrance: 400 citing papers, 3.6% of this breakdownAustralia: 381 citing papers, 3.5% of this breakdownNetherlands: 302 citing papers, 2.7% of this breakdownSpain: 301 citing papers, 2.7% of this breakdownJapan: 277 citing papers, 2.5% of this breakdownBelgium: 268 citing papers, 2.4% of this breakdown
0%28.4%Other 26.9%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology47.9%
  • Medicine40.1%
  • Computer Science4.6%
  • Immunology and Microbiology3.7%
  • Engineering0.9%
  • Chemistry0.6%
  • Other2.2%

Topics

  • Breast Cancer Treatment Studies8.8%
  • Cancer Immunotherapy and Biomarkers5.3%
  • Cancer Cells and Metastasis4.6%
  • Cancer Genomics and Diagnostics4.2%
  • HER2/EGFR in Cancer Research3.5%
  • Breast Lesions and Carcinomas2.6%
  • Other71%

Coauthors

All papers

Open in search
  1. The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014

    Authors: Roberto Salgado, Carsten Denkert, Sandra Demaria, Nicolas Sirtaine, Frederick Klauschen, Giancarlo Pruneri, Stephan Wienert, Gert Van den Eynden, Frederick L. Baehner, Frédérique Penault‐Llorca, Edith A. Perez, E. Aubrey Thompson, W. Fraser Symmans, Andrea L. Richardson, Jane Brock, Carmen Criscitiello, Helen D. Bailey, M. Ignatiadis, Giuseppe Floris, Joseph A. Sparano, Zuzana Kos, Torsten O. Nielsen, David L. Rimm, Kimberly H. Allison, Jorge S. Reis‐Filho, Sibylle Loibl, Christos Sotiriou, Giuseppe Viale, Sunil Badve, Sylvia Adams, Karen Willard‐Gallo, Sherene Loi - Annals of Oncology 2014 cited by 3,136

  2. A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer

    Authors: Soonmyung Paik, Steven Shak, Gong Tang, Chungyeul Kim, Joffre Baker, Maureen Cronin, Frederick L. Baehner, Michael G. Walker, Drew Watson, Taesung Park, W. Douglas B. Hiller, Edwin R. Fisher, D. Lawrence Wickerham, John Bryant, Norman Wolmark - New England Journal of Medicine 2004 cited by 6,358

  3. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes

    Authors: Richard M. Neve, Koei Chin, Jane Fridlyand, Jennifer Yeh, Frederick L. Baehner, Tea Fevr, Laura Ashley Clark, Nora Bayani, Jean‐Philippe Coppé, Frances Tong, Terry Speed, Paul T. Spellman, Sandy DeVries, Anna Lapuk, N. Wang, Wen‐Lin Kuo, Jackie L. Stilwell, Daniel Pinkel, Donna G. Albertson, Frederic M. Waldman, Frank McCormick, Robert B. Dickson, Michael D. Johnson, Marc E. Lippman, Stephen P. Ethier, Adi F. Gazdar, Joe W. Gray - Cancer Cell 2006 cited by 3,231

  4. Breast cancer prognostic classification in the molecular era: the role of histological grade

    Authors: Emad A. Rakha, Jorge S. Reis‐Filho, Frederick L. Baehner, David J. Dabbs, Thomas Decker, Vincenzo Eusebi, Stephen B. Fox, Shu Ichihara, Jocelyne Jacquemier, Sunil R. Lakhani, José Palacios, Andrea L. Richardson, Stuart J. Schnitt, Fernando Schmitt, Puay‐Hoon Tan, Gary M. Tse, Sunil Badve, Ian O. Ellis - Breast Cancer Research 2010 cited by 992

  5. Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer

    Authors: Soonmyung Paik, Gong Tang, Steven Shak, Chungyeul Kim, Joffre Baker, Wanseop Kim, Maureen Cronin, Frederick L. Baehner, Drew Watson, John Bryant, Joseph P. Costantino, Charles E. Geyer, D. Lawrence Wickerham, Norman Wolmark - Journal of Clinical Oncology 2006 cited by 2,577

  6. A 17-gene Assay to Predict Prostate Cancer Aggressiveness in the Context of Gleason Grade Heterogeneity, Tumor Multifocality, and Biopsy Undersampling

    Authors: Eric A. Klein, Matthew R. Cooperberg, Cristina Magi‐Galluzzi, Jeffry Simko, Sara M. Falzarano, Tara Maddala, June M. Chan, Jianbo Li, Janet E. Cowan, Athanasios C. Tsiatis, Diana B. Cherbavaz, Robert J. Pelham, Imelda Tenggara-Hunter, Frederick L. Baehner, Dejan Knezevic, Phillip G. Febbo, Steven Shak, Michael W. Kattan, Mark Lee, Peter R. Carroll - European Urology 2014 cited by 670

  7. Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial

    Authors: Kathy S. Albain, William E. Barlow, Steven Shak, Gabriel N. Hortobágyi, Robert B. Livingston, I‐Tien Yeh, Peter M. Ravdin, Roberto Bugarini, Frederick L. Baehner, Nancy E. Davidson, George W. Sledge, Eric P. Winer, Clifford A. Hudis, James N. Ingle, Edith A. Perez, Kathleen I. Pritchard, Lois E. Shepherd, Julie R. Gralow, Carl Yoshizawa, D. Craig Allred, C. Kent Osborne, Daniel F. Hayes - The Lancet Oncology 2009 cited by 1,405

  8. Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists

    Authors: Sunil Badve, David J. Dabbs, Stuart J. Schnitt, Frederick L. Baehner, Thomas Decker, Vincenzo Eusebi, Stephen B. Fox, Shu Ichihara, Jocelyne Jacquemier, Sunil R. Lakhani, José Palacios, Emad A. Rakha, Andrea L. Richardson, Fernando Schmitt, Puay‐Hoon Tan, Gary M. Tse, Britta Weigelt, Ian O. Ellis, Jorge S. Reis‐Filho - Modern Pathology 2010 cited by 674

  9. Comparison of the Performance of 6 Prognostic Signatures for Estrogen Receptor–Positive Breast Cancer

    Authors: Ivana Šestak, Richard Buus, Jack Cuzick, Peter Dubsky, Ralf Kronenwett, Carsten Denkert, Sean Ferree, Dennis C. Sgroi, Catherine A. Schnabel, Frederick L. Baehner, Elizabeth Mallon, Mitch Dowsett - JAMA Oncology 2018 cited by 330

  10. A Multigene Expression Assay to Predict Local Recurrence Risk for Ductal Carcinoma In Situ of the Breast

    Authors: Lawrence J. Solin, Robert P. Gray, Frederick L. Baehner, Steven M. Butler, Lorie L. Hughes, Carl Yoshizawa, Diana B. Cherbavaz, S. Shak, David L. Page, G. W. Sledge, Nancy E. Davidson, J. N. Ingle, Edith A. Perez, W. C. Wood, Joseph A. Sparano, S Badve - JNCI Journal of the National Cancer Institute 2013 cited by 523

  11. Prediction of Risk of Distant Recurrence Using the 21-Gene Recurrence Score in Node-Negative and Node-Positive Postmenopausal Patients With Breast Cancer Treated With Anastrozole or Tamoxifen: A TransATAC Study

    Authors: Mitch Dowsett, Jack Cuzick, Christopher Wale, John Forbes, Elizabeth A. Mallon, Janine Salter, Emma M. Quinn, Anita K. Dunbier, Michael Baum, Aman U. Buzdar, Anthony Howell, Roberto Bugarini, Frederick L. Baehner, Steven Shak - Journal of Clinical Oncology 2010 cited by 729

  12. The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: a retrospective of the last decade

    Authors: Britta Weigelt, Frederick L. Baehner, Jorge S. Reis‐Filho - The Journal of Pathology 2009 cited by 484

  13. Validation Study of a Quantitative Multigene Reverse Transcriptase–Polymerase Chain Reaction Assay for Assessment of Recurrence Risk in Patients With Stage II Colon Cancer

    Authors: Richard Gray, Philip Quirke, Kelly Handley, Margarita Lopatin, Laura Magill, Frederick L. Baehner, Claire Beaumont, Kim M. Clark-Langone, Carl Yoshizawa, Mark Lee, Drew Watson, Steven Shak, David Kerr - Journal of Clinical Oncology 2011 cited by 376

  14. Association of Stromal Tumor-Infiltrating Lymphocytes With Recurrence-Free Survival in the N9831 Adjuvant Trial in Patients With Early-Stage HER2-Positive Breast Cancer

    Authors: Edith A. Perez, Karla V. Ballman, Kathy S. Tenner, E. Aubrey Thompson, Sunil Badve, Helen D. Bailey, Frederick L. Baehner - JAMA Oncology 2015 cited by 232

  15. Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer

    Authors: Elisabeth R. Garwood, Anjali S. Kumar, Frederick L. Baehner, Dan H. Moore, Alfred Au, Nola M. Hylton, Chris I. Flowers, Judy E. Garber, Beth‐Ann Lesnikoski, E. Shelley Hwang, O. Olopade, Elisa Port, Michael J. Campbell, Laura J. Esserman - Breast Cancer Research and Treatment 2009 cited by 217

  16. Differential impact of prognostic parameters in hormone receptor–positive lobular breast cancer

    Authors: Matthias Christgen, Oleg Gluz, Nadia Harbeck, Ronald Kates, Mieke Raap, Henriette Christgen, Michael Clemens, Wolfram Malter, Benno Nuding, Bahriye Aktas, Sherko Küemmel, Toralf Reimer, Andrea Stefek, Petra Krabisch, Marianne Just, Doris Augustin, Monika Graeser, Frederick L. Baehner, Rachel Wuerstlein, Ulrike Nitz, Hans Kreipe, the West German Study Group PlanB Investigators - Cancer 2020 cited by 57

  17. Ultrasensitive Circulating Tumor DNA Pilot Study Distinguishes Complete Response and Partial Response With Immunotherapy in Patients With Metastatic Renal Cell Carcinoma

    Authors: Alex Chehrazi‐Raffle, Ramya Muddasani, Nazlı Dizman, Joann Hsu, Luís Meza, Zeynep Büşra Zengin, Jasnoor Malhotra, Neal Shiv Chawla, Tanya B. Dorff, Tania Contente‐Cuomo, Devin Dinwiddie, Bradon R. McDonald, Timothy K. McDaniel, Jeffrey M. Trent, Frederick L. Baehner, Muhammed Murtaza, Sumanta K. Pal - JCO Precision Oncology 2023 cited by 23

  18. Breast Cancer Growth Prevention by Statins

    Authors: Michael J. Campbell, Laura J. Esserman, Yamei Zhou, Mark Shoemaker, Margaret Lobo, Elizabeth Borman, Frederick L. Baehner, Anjali S. Kumar, Kelly Adduci, Corina Marx, Emanuel F. Petricoin, Lance A. Liotta, Mary Winters, Stephen C. Benz, Christopher C. Benz - Cancer Research 2006 cited by 351

  19. Relationship Between Tumor Gene Expression and Recurrence in Four Independent Studies of Patients With Stage II/III Colon Cancer Treated With Surgery Alone or Surgery Plus Adjuvant Fluorouracil Plus Leucovorin

    Authors: Michael J. O’Connell, Ian C. Lavery, Greg Yothers, Soonmyung Paik, Kim M. Clark-Langone, Margarita Lopatin, Drew Watson, Frederick L. Baehner, Steven Shak, Joffre Baker, J. Wayne Cowens, Norman Wolmark - Journal of Clinical Oncology 2010 cited by 299

  20. Surgical Excision Without Radiation for Ductal Carcinoma in Situ of the Breast: 12-Year Results From the ECOG-ACRIN E5194 Study

    Authors: Lawrence J. Solin, Robert J. Gray, Lorie L. Hughes, William C. Wood, Mary Ann Lowen, Sunil Badve, Frederick L. Baehner, James N. Ingle, Edith A. Perez, Abram Recht, Joseph A. Sparano, Nancy E. Davidson - Journal of Clinical Oncology 2015 cited by 272

  21. Bladder Cancer Outcome and Subtype Classification by Gene Expression

    Authors: Ekaterini Blaveri, Jeff Simko, James E. Korkola, Jeremy L. Brewer, Frederick L. Baehner, Kshama Mehta, Sandy DeVries, Theresa M. Koppie, Sunanda Pejavar, Peter R. Carroll, Frederic M. Waldman - Clinical Cancer Research 2005 cited by 335

  22. β1 Integrin Inhibitory Antibody Induces Apoptosis of Breast Cancer Cells, Inhibits Growth, and Distinguishes Malignant from Normal Phenotype in Three Dimensional Cultures and In vivo

    Authors: Catherine C. Park, Hui Zhang, Maria G. Pallavicini, Joe W. Gray, Frederick L. Baehner, Chong J. Park, Mina J. Bissell - Cancer Research 2006 cited by 324

  23. A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone

    Authors: Eileen Rakovitch, Sharon Nofech‐Mozes, Wedad Hanna, Frederick L. Baehner, Refik Saskin, Steven M. Butler, Alan B. Tuck, Sandip Sengupta, Leela Elavathil, Prashant Jani, M. Bonin, Martin C. Chang, Susan J. Robertson, Elzbieta Slodkowska, Cindy Fong, Joseph M Anderson, Farid Jamshidian, Dave P. Miller, Diana B. Cherbavaz, Steven Shak, Lawrence Paszat - Breast Cancer Research and Treatment 2015 cited by 235

  24. Characterizing the immune microenvironment in high-risk ductal carcinoma in situ of the breast

    Authors: Michael J. Campbell, Frederick L. Baehner, Tess A. O’Meara, Ekene Ojukwu, Booyeon J. Han, Rita A. Mukhtar, Vickram J. Tandon, Max Endicott, Zelos Zhu, Jasmine Wong, Gregor Krings, Alfred Au, Joe W. Gray, Laura J. Esserman - Breast Cancer Research and Treatment 2016 cited by 110